Elite in Hypertrichosis-Acromegaloid Facial Appearance Syndrome

Dr. Pamela Freda

Endocrinology
Trustees Of Columbia University In The City Of New York
1150 Saint Nicholas Ave, 
New York, NY 
Offers Telehealth
Elite in Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Trustees Of Columbia University In The City Of New York
1150 Saint Nicholas Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Pamela Freda is an Endocrinologist in New York, New York. Dr. Freda is rated as an Elite provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. Her top areas of expertise are Acromegaly, Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, and Pituitary Tumor.

Her clinical research consists of co-authoring 49 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 37 articles and participated in 3 clinical trials in the study of Hypertrichosis-Acromegaloid Facial Appearance Syndrome.

Specialties
Endocrinology
Licenses
Internal Medicine in NY
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Nippon Life
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
1150 Saint Nicholas Ave, New York, NY 10032

Additional Areas of Focus

Dr. Freda has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Prospective Study of Outcome After Therapy for Acromegaly
A Prospective Study of Outcome After Therapy for Acromegaly
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Procedure, Drug, Diagnostic test
Treatment Patterns and Treatment Outcomes in a New York City Based Cohort of 520 Patients With Acromegaly
Treatment Patterns and Treatment Outcomes in a New York City Based Cohort of 520 Patients With Acromegaly
Enrollment Status: Completed
Publish Date: May 13, 2025
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Radiation, Procedure
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
Enrollment Status: Completed
Publish Date: May 29, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

49 Total Publications

Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.
Journal: Nature reviews. Endocrinology
Published: May 12, 2025
Similar Doctors
Distinguished in Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Dr. Eliza Geer
Endocrinology
Distinguished in Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Dr. Eliza Geer
Endocrinology

Memorial Endocrine Group

205 E 64th St, 
New York, NY 
 (5.4 miles away)
646-449-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eliza Geer is an Endocrinologist in New York, New York. Dr. Geer is rated as an Elite provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. Her top areas of expertise are Cushing's disease, Cushing's syndrome, Pituitary Tumor, and Acromegaly.

Advanced in Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Dr. Adriana P. Kuker
Endocrinology
Advanced in Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Dr. Adriana P. Kuker
Endocrinology

Lawrence Medical Associates PC

685 White Plains Rd, 
Eastchester, NY 
 (11.0 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Adriana Kuker is an Endocrinologist in Eastchester, New York. Dr. Kuker is rated as an Advanced provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. Her top areas of expertise are Osteoporosis, Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, and Postmenopausal Osteoporosis.

Experienced in Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Dr. Georgiana Dobri
Endocrinology
Experienced in Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Dr. Georgiana Dobri
Endocrinology

Weill Medical College Of Cornell

525 E 68th St, 
New York, NY 
 (5.3 miles away)
212-746-6320
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Georgiana Dobri is an Endocrinologist in New York, New York. Dr. Dobri is rated as a Distinguished provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. Her top areas of expertise are Pituitary Tumor, Prolactinoma, Craniopharyngioma, Hypothalamic Tumor, and Endoscopic Transnasal Transsphenoidal Surgery.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Freda's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile